173 related articles for article (PubMed ID: 29345291)
21. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
24. miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression.
Han LL; Yin XR; Zhang SQ
Cell Physiol Biochem; 2018; 51(3):1179-1192. PubMed ID: 30481780
[TBL] [Abstract][Full Text] [Related]
25. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression.
Xiao JN; Yan TH; Yu RM; Gao Y; Zeng WL; Lu SW; Que HX; Liu ZP; Jiang JH
J Cancer Res Clin Oncol; 2017 Jun; 143(6):981-990. PubMed ID: 28271214
[TBL] [Abstract][Full Text] [Related]
27. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
29. miR-1306-3p targets FBXL5 to promote metastasis of hepatocellular carcinoma through suppressing snail degradation.
He ZJ; Li W; Chen H; Wen J; Gao YF; Liu YJ
Biochem Biophys Res Commun; 2018 Oct; 504(4):820-826. PubMed ID: 30219228
[TBL] [Abstract][Full Text] [Related]
30. miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.
Chang L; Li K; Guo T
Clin Transl Oncol; 2017 Jun; 19(6):695-703. PubMed ID: 27864783
[TBL] [Abstract][Full Text] [Related]
31. MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1.
Li T; Li M; Hu S; Cheng X; Gao Y; Jiang S; Yu Q; Zhang C; Sun P; Xian W; Song Z; Zhang Y; Zheng Q
Int J Biol Macromol; 2017 Oct; 103():1054-1061. PubMed ID: 28539268
[TBL] [Abstract][Full Text] [Related]
32. KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
Han J; Wang F; Lan Y; Wang J; Nie C; Liang Y; Song R; Zheng T; Pan S; Pei T; Xie C; Yang G; Liu X; Zhu M; Wang Y; Liu Y; Meng F; Cui Y; Zhang B; Liu Y; Meng X; Zhang J; Liu L
Oncogene; 2019 Jan; 38(3):406-420. PubMed ID: 30115976
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
Chang RM; Yang H; Fang F; Xu JF; Yang LY
Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
[TBL] [Abstract][Full Text] [Related]
35. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
Sun X; Liu Y; Li M; Wang M; Wang Y
Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
[TBL] [Abstract][Full Text] [Related]
36. miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker.
Yang J; Liu X; Yuan X; Wang Z
Oncol Rep; 2015 Sep; 34(3):1415-23. PubMed ID: 26134929
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.
Kim HS; Lee KS; Bae HJ; Eun JW; Shen Q; Park SJ; Shin WC; Yang HD; Park M; Park WS; Kang YK; Nam SW
Oncotarget; 2015 Apr; 6(10):8089-102. PubMed ID: 25797269
[TBL] [Abstract][Full Text] [Related]
38. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
Du X; Fan W; Chen Y
Gene; 2018 May; 657():30-38. PubMed ID: 29505836
[TBL] [Abstract][Full Text] [Related]
39. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN.
Zhang D; Zhou P; Wang W; Wang X; Li J; Sun X; Zhang L
Oncol Rep; 2016 Jan; 35(1):366-74. PubMed ID: 26499912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
